A
Antonio Craxì
Researcher at University of Palermo
Publications - 699
Citations - 44773
Antonio Craxì is an academic researcher from University of Palermo. The author has contributed to research in topics: Hepatitis C & Cirrhosis. The author has an hindex of 86, co-authored 659 publications receiving 39463 citations. Previous affiliations of Antonio Craxì include University of Pavia & University of Paris-Sud.
Papers
More filters
Journal ArticleDOI
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies
Salvatore Petta,Marcello Maida,Fabio Salvatore Macaluso,Marco Barbara,Anna Licata,Antonio Craxì,Calogero Cammà +6 more
TL;DR: In a meta-analysis of published studies, individuals with HCV infections were found to be at increased risk for CVD-related morbidity and mortality-especially patients with diabetes and hypertension.
Journal ArticleDOI
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease
Salvatore Petta,Marcello Maida,Fabio Salvatore Macaluso,Vito Di Marco,Calogero Cammà,Daniela Cabibi,Antonio Craxì +6 more
TL;DR: In patients with nonalcoholic fatty liver disease, the presence of severe steatosis, detected by histology or by US, should always be taken into account in order to avoid overestimations of liver fibrosis assessed by transient elastography.
Journal ArticleDOI
The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report.
Nabil Antaki,Antonio Craxì,Sanaa M. Kamal,Rami Moucari,Schalk Van der Merwe,Samir Haffar,Adrián Gadano,Nizar N. Zein,Ching-Lung Lai,Jean-Michel Pawlotsky,E. Jenny Heathcote,Geoffrey Dusheiko,Patrick Marcellin +12 more
TL;DR: Hepatitis C virus genotypes 4, 5 and 6 represent >20% of all HCV cases worldwide and are highly prevalent in sub‐Saharan Africa and in the Middle East, while HCV‐6 is found in Hong Kong, Vietnam, Thailand and Myanmar and also in American and Australian from Asian origin.
Journal ArticleDOI
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
Benedetta Donati,Paola Dongiovanni,Stefano Romeo,Stefano Romeo,Marica Meroni,Misti Vanette McCain,Misti Vanette McCain,Luca Miele,Salvatore Petta,S. Maier,Chiara Rosso,Laura De Luca,Ester Vanni,Stefania Grimaudo,Renato Romagnoli,Fabio Colli,Flaminia Ferri,Rosellina Margherita Mancina,Paula Iruzubieta,Antonio Craxì,Anna Ludovica Fracanzani,Antonio Grieco,Stefano Ginanni Corradini,Alessio Aghemo,Massimo Colombo,Giorgio Soardo,Elisabetta Bugianesi,Helen L. Reeves,Helen L. Reeves,Quentin M. Anstee,Quentin M. Anstee,Silvia Fargion,Luca Valenti +32 more
TL;DR: The MBOat7 rs641738 T allele is associated with reduced MBOAT7 expression and may predispose to HCC in patients without cirrhosis, suggesting it should be evaluated in future prospective studies aimed at stratifying NAFLD-HCC risk.
Journal ArticleDOI
Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
Calogero Cammà,Savino Bruno,Vito Di Marco,Danilo Di Bona,Maria Grazia Rumi,Maria Vinci,Chiara Rebucci,A. Cividini,Giuseppe Pizzolanti,Ernesto Minola,Mario U. Mondelli,Massimo Colombo,Giovanbattista Pinzello,Antonio Craxì +13 more
TL;DR: In nondiabetic European patients with genotype 1 hepatitis C at low risk for the metabolic syndrome, the prevalence of steatosis was nearly 60%, and IR is a risk factor for moderate/severe steatotic, especially in men.